Hydrogen Therapy Helps Stroke Recovery After Failed Surgery

TL;DR

Adjunctive hydrogen–rhodiola therapy in a patient with internal carotid artery (ICA) occlusion improved motor recovery and immune regulation, suggesting a safe neuroprotective benefit post-stroke.

Key Finding

A single patient with severe stroke from internal carotid artery occlusion showed marked motor recovery (from paralysis to normal strength) over six months when treated with molecular hydrogen-rhodiola as an adjunct to surgery, accompanied by changes in immune markers suggesting reduced inflammation.

Summary

This case report describes one patient with a severe stroke caused by a blocked artery in the neck who received molecular hydrogen-rhodiola capsules as an additional treatment after surgery. Over six months, the patient's paralyzed arm and leg regained significant strength, and blood tests showed changes in immune cells that may have helped reduce inflammation in the brain. The patient tolerated the treatment well with no reported side effects.

Practical Takeaway

While this case report suggests molecular hydrogen-rhodiola may be safe and potentially beneficial for stroke recovery, it describes only one patient's experience and cannot establish whether the treatment caused the improvement or whether it would help others. Much larger, controlled studies would be needed before drawing conclusions about its effectiveness for stroke patients.

Abstract (excerpt)

Objectives: Acute ischemic stroke caused by internal carotid artery (ICA) occlusion carries high risks of disability and death. While treatments such as thrombolysis, mechanical thrombectomy, and revascularization offer benefits, many patients experience limited recovery. Molecular hydrogen…

Read the full abstract via DOI